Journal ArticleAm Heart J · February 2026
Rare cardiovascular diseases, while individually uncommon, collectively affect millions of people worldwide and are associated with significant morbidity, mortality, and economic burden. Despite this considerable impact, most rare cardiovascular diseases l ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 13, 2025
BACKGROUND: Infectious complications are common in patients implanted with HeartMate 3 (HM3) left ventricular assist devices (LVAD). Despite these issues, some patients with LVAD-specific infection are ultimately considered for heart transplant (HT). The i ...
Full textLink to itemCite
Journal ArticleAm Heart J · November 2025
Affective debriefs in the Intensive Care Unit (ICU) are defined as protected time and space for physicians to routinely discuss the emotions surrounding difficult cases, normalize grief, and acknowledge the work that affects physicians most. We highlight t ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · November 2025
BACKGROUND: Previous single-center studies identified an association between pretransplant durable left ventricular assist device (LVAD) support and severe primary graft dysfunction (PGD) following heart transplantation (HT). OBJECTIVES: The current study ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · September 2025
Despite improvements in managing earlier stage heart disease, the population of patients needing heart transplants continues to increase in the United States. Fortunately, novel methods of procuring and preserving donor hearts, including the use of ex-vivo ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 7, 2025
BACKGROUND: Out-of-sequence (OOS) allocation is a mechanism by which donor organs are offered outside the standard match run, typically to expedite the placement of hard-to-match or time-sensitive allografts. Rising OOS rates are described in abdominal org ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · July 2025
BACKGROUND: The impact of regional differences on primary graft dysfunction (PGD) after heart transplantation (HT) has not been assessed. This study aims to compare differences in the incidence, risk factors, and outcomes of severe PGD in the US, Canada, a ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · June 2024
AIMS: The PARACOR-19 randomized controlled trial (RCT) was designed to examine the effects of sacubitril/valsartan on markers of cardiac injury, inflammation, structure, and function among patients who have recovered from acute coronavirus disease 2019 (CO ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · May 2024
BACKGROUND: Heart transplant (HT) in recipients with left ventricular assist devices (LVADs) is associated with poor early post-HT outcomes, including primary graft dysfunction (PGD). As complicated heart explants in recipients with LVADs may produce longe ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2024
Historically, heart transplantation (HT) has relied on the use of traditional cold storage for donor heart preservation. This organ preservation modality has several limitations, including the risk for ischemic and cold-induced graft injuries that may cont ...
Full textLink to itemCite
Journal ArticleClin Transplant · October 2023
INTRODUCTION: Heart transplant (HT) recipients with prior exposure to cytomegalovirus (CMV R+) are considered intermediate risk for CMV-related complications. Consensus guidelines allow for either universal prophylaxis (UP) or preemptive therapy (PET) (ser ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · April 2023
Kalra PR, Cleland JG, Petrie MC, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022;400:2199-2 ...
Full textLink to itemCite
Journal ArticleSci Rep · June 2, 2022
Heart failure with reduced ejection fraction (HFrEF) is increasingly treated with medications for type 2 diabetes mellitus (T2DM). Whether metabolic derangements in HFrEF and T2DM are associated with differential outcomes remains unclear. Therefore, unders ...
Full textLink to itemCite
Journal ArticleJ Card Fail · March 2021
BACKGROUND: Prior analyses suggest an association between formula-based plasma volume (PV) estimates and outcomes in heart failure (HF). We assessed the association between estimated PV status by the Duarte-ePV and Kaplan Hakim (KH-ePVS) formulas, and in-h ...
Full textLink to itemCite
Journal ArticlePulm Circ · 2021
Pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. Obstructive sleep apnea (OSA) is increasingly recognized in the aging population, especially with the rising obesity epidemic. The impact of OSA on inpatient mortality in P ...
Full textLink to itemCite
Journal ArticleJAMA Dermatol · February 1, 2020
IMPORTANCE: Psoriasis, a chronic inflammatory skin disease associated with accelerated noncalcified coronary burden (NCB) by coronary computed tomography angiography (CCTA), accelerates lipoprotein oxidation in the form of oxidized modified lipoproteins. A ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Imaging · February 2020
OBJECTIVES: This study hypothesized that there is an association between chronic stress (as indexed by resting amygdalar activity [AmygA]), hematopoietic system activity (HMPA), and subclinical cardiovascular indexes (aortic vascular inflammation [VI] and ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · September 2019
BACKGROUND: Women comprise approximately one-third of the advanced heart failure population but may receive fewer advanced heart failure therapies including left ventricular assist devices (LVADs). During the early pulsatile-flow device era, women had high ...
Full textLink to itemCite
Journal ArticleLupus Sci Med · 2019
OBJECTIVE: Subjects with SLE display an enhanced risk of atherosclerotic cardiovascular disease (CVD) that is not explained by Framingham risk. This study sought to investigate the utility of nuclear MR (NMR) spectroscopy measurements of serum lipoprotein ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · October 1, 2018
IMPORTANCE: Inflammation is critical to atherosclerosis. Psoriasis, a chronic inflammatory disease associated with early cardiovascular events and increased aortic vascular inflammation (VI), provides a model to study the process of early atherogenesis. Fl ...
Full textLink to itemCite
ConferenceArteriosclerosis, Thrombosis, and Vascular Biology · May 2018
Introduction:
Psoriasis (PSO), a chronic inflammatory disease associated with increased prevalence of both stress and coronary artery disease, provides a model to study the role of perceived stress in ...
Full textCite
Journal ArticleJCI Insight · April 19, 2018
BACKGROUND: Systemic lupus erythematosus (SLE) is associated with enhanced risk of atherosclerotic cardiovascular disease not explained by Framingham risk score (FRS). Immune dysregulation associated to a distinct subset of lupus proinflammatory neutrophil ...
Full textLink to itemCite
Journal ArticleJ Am Acad Dermatol · October 2017
BACKGROUND: Psoriasis is associated with risk of cardiovascular (CV) disease (CVD) and a major adverse CV event (MACE). Whether psoriasis duration affects risk of vascular inflammation and MACEs has not been well characterized. OBJECTIVES: We utilized two ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · September 1, 2017
IMPORTANCE: Inflammation is critical in the development of atherosclerosis. Psoriasis is a chronic inflammatory skin disease that is associated with increased vascular inflammation by 18fluorodeoxyglucose positron emission tomography/computed tomography in ...
Full textLink to itemCite
Journal ArticleCirculation · July 18, 2017
BACKGROUND: Psoriasis, a chronic inflammatory disease associated with an accelerated risk of myocardial infarction, provides an ideal human model to study inflammatory atherogenesis in vivo. We hypothesized that the increased cardiovascular risk observed i ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · February 15, 2017
Obesity may associate with greater cardiovascular risk in adults with congenital heart disease (ACHD) than in the general population. As ACHD often have exercise limitations, they may be uniquely predisposed to obesity. Nevertheless, obesity prevalence in ...
Full textLink to itemCite
Journal ArticleCirc Res · November 11, 2016
RATIONALE: GlycA, an emerging inflammatory biomarker, predicted cardiovascular events in population-based studies. Psoriasis, an inflammatory disease associated with increased cardiovascular risk, provides a model to study inflammatory biomarkers in cardio ...
Full textLink to itemCite
Journal ArticleAtherosclerosis · August 2016
BACKGROUND AND AIMS: Psoriasis is a chronic inflammatory disorder associated with vascular inflammation, measured by 18-fluorodeoxyglucose positron emission tomography/computed tomography (18-FDG PET/CT), and an increased risk of myocardial infarction. Pat ...
Full textLink to itemCite